Featured researchA real report from the desk, on public data — this is what every report looks like.

ZBRA

ZEBRA TECHNOLOGIES CORPEvidence as of 2026-09-03

Overview · ZEBRA TECHNOLOGIES CORP

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers, which produce labels, wristbands, tickets, receipts, and plastic cards; dye-…

SectorTechnology
IndustryCommunication Equipment
Typeequity
ExchangeNASDAQ
Employees10,500
www.zebra.com

Management team

Start your 7-day free trial to see the full management team.

Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.

Moneyta sentiment

Where the published evidence leans after the desk debated it — not a rating or a recommendation.

Constructivehigh confidence
−2 · strongly unfavorable0 · balanced+2 · strongly favorable

+0.8 on a −2 to +2 scale.

What builds the score

Fundamentals
+1.5
Ownership and flow
+0.0

Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.

News tonecontext · not scored+0.8 observed
5 favorable1 neutral0 unfavorableacross 5 outlets · 7 stories deduped to 6 storylines

Editor's note

Written after the debate settled — the rest of the page is the evidence behind it.

GoodwinAI editor

The desk’s surviving evidence produces a constructive balance (+0.8 of a possible +2; confidence high). Revenue in the three‑month sequence rose from $ 1,293,000,000 in the quarter 2025-03-30 to 2025-06-28 (3mo) to $ 1,557,000,000 in the quarter 2026-04-05 to 2026-07-04 (3mo). Gross profit climbed from $ 616,000,000 to $ 825,000,000 across the same sequence, and gross margin expanded from about 47.7% to about 53.0% over the reported quarters.

Operating income increased from $ 183,000,000 in the quarter 2025-03-30 to 2025-06-28 (3mo) to $ 321,000,000 in the quarter 2026-04-05 to 2026-07-04 (3mo), while net income rose from $ 112,000,000 to $ 233,000,000. Weighted‑average diluted shares outstanding fell from 51,282,273 to 48,129,265 across the same pair of quarterly comparisons, and point‑in‑time common shares outstanding moved from 49,191,704 as of 2026-02-05 to 47,310,660 as of 2026-07-28. Valuation signals in the packet show trailing‑12‑month FCF of $ 340,000,000, a price to trailing‑12‑month FCF of 49.7, EV/EBITDA of 17.71, and a trailing P/E of 29.93; the model-implied FCF growth rate consistent with today’s price is 32.82%.

How this note was made

every stage ran before the note was written
Analystsread the evidence
Debatebull ⇄ bear ×2
Chairrules on every claim
Riskstress-tests the read
Sentimentweighs what survived
Editorwrites the note

Analyst desk

Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.

MercerAI fundamentals analyst
+2.0

Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.

Revenue rose from $1,293,000,000 in the quarter 2025-03-30 to 2025-06-28 (3mo) to $1,557,000,000 in the quarter 2026-04-05 to 2026-07-04 (3mo).

XBRL companyfacts · 0001628280-26-052550

Gross profit increased from $616,000,000 in the quarter 2025-03-30 to 2025-06-28 (3mo) to $825,000,000 in the quarter 2026-04-05 to 2026-07-04 (3mo).

XBRL companyfacts · 0001628280-26-052550
OakesAI filings and risk analyst
+0.0

Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.

Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.

Which filings the desk reads

The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.

NashAI market signals analyst
no data on file

Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.

No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.

EllisAI ownership and flow analyst
+0.0

Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.

As of 2026-09-02, ZBRA appears in the iShares Core S&P 500 ETF (IVV) with a fund weight of 0.02%.

ETF constituents · market data

The provided ownership evidence contains a single ETF membership record for ZBRA (IVV at 0.02%); no other ETF weights or institutional holdings are present in the supplied data.

ETF constituents · market data
YatesAI news analyst
+1.0

Reads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.

In early September 2026, University Health disclosed rolling out Zebra Technologies’ TC5, HC2X/HC5X mobile computers and ZQ600 Plus mobile printers to more than 90% of its frontline inpatient staff to streamline bedside workflows and reduce communication bottlenecks.

News · simplywall.st · 2026-09-03

A press release dated September 02, 2026 announced University Health’s deployment of Zebra mobile computers and printers to eliminate callbacks and modernize workflows.

News · finance.yahoo.com · 2026-09-02
TalbotAI insider activity analyst
no data on file

Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.

No insider transactions on file in the trailing 180 days.

ArcherAI valuation analyst
−1.0

Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.

The market-implied free cash flow (FCF) growth rate that today's price would justify, under the model's stated discount and terminal assumptions, is 32.82%.

Valuation inputs · SEC XBRL + stored EOD close

Price to trailing‑12‑month FCF is 49.7, implying the market is paying about fifty times last‑twelve‑month FCF.

Valuation inputs · SEC XBRL + stored EOD close

Debate and risk review

A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.

Debate1 round · 4 claims contested

A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.

The bull case

Several company-specific operating signals in the supplied evidence jointly support a favorable read. Revenue, gross profit and operating income each show multi-quarter improvement (fundamentals-0, fundamentals-1, fundamentals-3) while gross margin expanded consistently quarter-to-quarter from ~47.7% to ~53.0% (fundamentals-2), indicating improving unit economics rather than a one-off revenue blip. Net income rose alongside a declining share base (fundamentals-4, fundamentals-5), so earnings per-share dynamics appear strengthened by both profit growth and share count reduction. Recent customer deployments, product design awards, and investor conference activity (news-0, news-4, news-2) provide corroborating commercial and brand signals that align with the operating improvements. Valuation multiples that are neutral-to-positive in level relative to growth (EV/EBITDA 17.7, P/E ~29.9; valuation-2, valuation-3) temper the raw high-FCF multiple concerns and suggest some of the negative valuation indicators rely on a narrow FCF snapshot rather than the broader profitability trend.

The bear case

Chair's verdict, claim by claim

In early September 2026, University Health disclosed rolling out Zebra Technologies’ TC5, HC2X/HC5X mobile computers and ZQ600 Plus mobile printers to more than 90% of its frontline inpatient staff to streamline bedside workflows and reduce communication bottlenecks.Press reporting indicates University Health deployed Zebra’s TC5/HC2X/HC5X devices and ZQ600 Plus printers to ~90% of frontline inpatient staff as described in the cited news item.upheld
A press release dated September 02, 2026 announced University Health’s deployment of Zebra mobile computers and printers to eliminate callbacks and modernize workflows.A September 2, 2026 press release documents University Health’s deployment of Zebra mobile computers and printers, matching the claim.upheld
As of 2026-09-02, ZBRA appears in the iShares Core S&P 500 ETF (IVV) with a fund weight of 0.02%.The ETF membership record shows ZBRA in IVV with a 0.02% weight as of 2026-09-02 per the supplied ownership data.upheld
Risk review

Fragility · computed, not argued

balanced0.35

20 surviving claims rest on 10 distinct sources; the heaviest analyst carries 35% of them, and 100% of what the desk raised survived the debate.

Twenty surviving claims draw on ten distinct sources, so the read has some breadth, but a single analyst supplies over a third of the claims and every point the desk raised survived debate — both signs that the dataset is concentrated and that internal challenge was limited. In practice this means the findings are informative but somewhat fragile: they warrant attention while remaining sensitive to new filings, large market moves, or additional independent sources before being treated as robust.

Disconfirming evidence · base rates · falsifiers

Context

Outside consensus, and where this name already sits in your own portfolio.

The street's viewAnalyst consensus · third-party · 2026-09-02
Buy Hold Sell Target

Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.

What this was built from

Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.

10 filings· 1 cited

SEC XBRL filings

Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.

Read by Mercer+1.5 to the score

1 holdings record

Fund holdings

Which funds hold this name and at what weight, plus insider Form 4 filings.

Read by Ellis+0.0 to the score

8 headlines· 2 cited

News coverage

Recent headlines about this company, rating chatter excluded and nothing published after the report date.

Read by Yatesnothing survived

1 computation

Valuation inputs

TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.

Read by Archercontext only

1 record· 0 cited

Company profile

Sector, industry and company details.

1 record· 0 cited

Analyst consensus

Third-party consensus, shown for context only — it never enters Moneyta sentiment.

Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.

Social sentiment

Crowd chatter as an evidence stream.

Coming soon

Aggregated tone from public social feeds will join the desk as its own evidence stream — read by its own analyst, contested in the same debate, and shown with the same sourcing as every other claim. Until it earns that bar, nothing renders here.

RPT-fe00b7b6evidence ac2db1ce22adgenerated 9/3/2026, 5:20:36 AM · 68s13 model calls View trail

Written by AI, checked against sources

The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.

Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.

Get this for the tickers you actually hold

Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.

The full terminal on ZBRA Gold

Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.

Unlock

Institutional holders

Net institutional flow, Q/Q

Largest holder position

Insider buys, 90 days

Clustered insider value

Street target range

The real figures are for members. Educational analysis, not advice.

Educational analysis of published data. Moneyta does not give investment advice or make recommendations.